BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37060355)

  • 1. Benefit and risk evaluation of quinapril hydrochloride.
    Barkhordarian M; Lawrence JA; Ulusan S; Erbay MI; Aronow WS; Gupta R
    Expert Opin Drug Saf; 2023 Apr; 22(4):271-277. PubMed ID: 37060355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D; Frank GJ; Knapp LE; McLain RW
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinapril: a new second-generation ACE inhibitor.
    Cetnarowski-Cropp AB
    DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the clinical development of quinapril.
    Frank GJ
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and tolerability of quinapril.
    Knapp LE; Frank GJ; McLain R; Rieger MM; Posvar E; Singer R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S47-55. PubMed ID: 1691407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall tolerance and safety of quinapril in clinical trials.
    Frank GJ; Knapp LE; McLain RW
    Angiology; 1989 Apr; 40(4 Pt 2):405-15. PubMed ID: 2650583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
    Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril.
    Materson BJ
    Am J Cardiol; 1992 Apr; 69(10):46C-53C. PubMed ID: 1546639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
    J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of quinapril, a new ACE inhibitor.
    Frank GJ; Knapp LE; Olson SC; Phelps MC; Quade MM; Rieger MM; Sedman AJ
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S14-23. PubMed ID: 1691402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension].
    Schmidt BM; Smilde J; Oldenbroek C; Wehling M
    Med Klin (Munich); 1998 Dec; 93(12):701-6. PubMed ID: 10024837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cough induced by quinapril with resolution after changing to fosinopril.
    Sharif MN; Evans BL; Pylypchuk GB
    Ann Pharmacother; 1994 Jun; 28(6):720-2. PubMed ID: 7919557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitors in the treatment of hypertension in the older patient.
    Canter D; Frank G
    Eur Heart J; 1990 May; 11 Suppl D():33-43. PubMed ID: 2193809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
    Riegger GA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of quinapril in the elderly patient.
    Schnaper HW
    Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Life-threatening postoperative angioedema following treatment with an angiotensin converting enzyme inhibitor].
    Maier C
    Anaesthesist; 1995 Dec; 44(12):875-9. PubMed ID: 8594963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.